208 related articles for article (PubMed ID: 30361291)
21. The cyclin D1 G870A polymorphism and colorectal cancer susceptibility: a meta-analysis of 20 populations.
Zhang LQ; Huang XE; Wang J; Shang JQ; Bai J; Liu FY; Guan X; Zhou JN
Asian Pac J Cancer Prev; 2011; 12(1):81-5. PubMed ID: 21517236
[TBL] [Abstract][Full Text] [Related]
22. Cyclin D1 G870A polymorphism and breast cancer risk: a meta-analysis involving 23,998 subjects.
Yang J; Liu H; Lu S; Gao M; Du Q; Tang SC
Oncol Res; 2011; 19(12):519-25. PubMed ID: 22812184
[TBL] [Abstract][Full Text] [Related]
23. CCND1 G870A polymorphism contributes to the risk of esophageal cancer: An updated systematic review and cumulative meta-analysis.
Wen L; Hu YY; Yang GL; Liu DX
Biomed Rep; 2014 Jul; 2(4):549-554. PubMed ID: 24944806
[TBL] [Abstract][Full Text] [Related]
24. Cyclin D1 G870A polymorphism and colorectal cancer susceptibility: a meta-analysis of 20 populations.
Zhang LQ; Wang J; Shang JQ; Bai JL; Liu FY; Guan X; Zhou JN
Int J Colorectal Dis; 2011 Oct; 26(10):1249-55. PubMed ID: 21544737
[TBL] [Abstract][Full Text] [Related]
25. The CCND1 G870A gene polymorphism and brain tumor risk: a meta-analysis.
Qin LY; Zhao LG; Chen X; Li P; Yang Z; Mo WN
Asian Pac J Cancer Prev; 2014; 15(8):3607-12. PubMed ID: 24870765
[TBL] [Abstract][Full Text] [Related]
26. Effect of the CCND1 A870G polymorphism on prostate cancer risk: a meta-analysis of 3,820 cases and 3,825 controls.
Zheng M; Wan L; He X; Qi X; Liu F; Zhang DH
World J Surg Oncol; 2015 Feb; 13():55. PubMed ID: 25888980
[TBL] [Abstract][Full Text] [Related]
27. Association of CCND1 gene polymorphism with cervical cancer susceptibility in Caucasian population: a meta-analysis.
Yang M; Zhu H; Hu T; Liu S; Wang H
Int J Clin Exp Med; 2015; 8(8):12983-8. PubMed ID: 26550218
[TBL] [Abstract][Full Text] [Related]
28. Association between the G870A polymorphism of Cyclin D1 gene and glioma risk.
Zong H; Cao L; Ma C; Zhao J; Ming X; Shang M; Xu H
Tumour Biol; 2014 Aug; 35(8):8095-101. PubMed ID: 24840634
[TBL] [Abstract][Full Text] [Related]
29. CCND1 G870A polymorphism with altered cyclin D1 transcripts expression is associated with the risk of glioma in a Chinese population.
Chen X; Zhao T; Li L; Xu C; Zhang X; Tse V; Zhang T; Liu X; Lu F
DNA Cell Biol; 2012 Jun; 31(6):1107-13. PubMed ID: 22304571
[TBL] [Abstract][Full Text] [Related]
30. CCND1 G870A polymorphism is associated with increased risk of colorectal cancer, especially for sporadic colorectal cancer and in Caucasians: a meta-analysis.
Yang J; Zhang G; Chen J
Clin Res Hepatol Gastroenterol; 2012 Apr; 36(2):169-77. PubMed ID: 22322158
[TBL] [Abstract][Full Text] [Related]
31. Association between cyclin D1 (CCND1) polymorphism and gastric cancer risk in Japanese population.
Tahara T; Arisawa T; Shibata T; Yamashita H; Hirata I
Hepatogastroenterology; 2009; 56(93):1232-5. PubMed ID: 19760977
[TBL] [Abstract][Full Text] [Related]
32. Association Between the Polymorphism in miR-605 and Cancer Susceptibility: a PRISMA-Compliant Meta-Analysis.
Hu M; Yu Z; Luo D; Zhang H; Li J; Liang F; Chen R
Clin Lab; 2018 Oct; 64(11):. PubMed ID: 30549993
[No Abstract] [Full Text] [Related]
33. The CCND1 G870A polymorphism and susceptibility to bladder cancer.
Li J; Luo F; Zhang H; Li L; Xu Y
Tumour Biol; 2014 Jan; 35(1):171-7. PubMed ID: 23893383
[TBL] [Abstract][Full Text] [Related]
34. CCND1 G870A polymorphism contributes to breast cancer susceptibility: a meta-analysis.
Lu C; Dong J; Ma H; Jin G; Hu Z; Peng Y; Guo X; Wang X; Shen H
Breast Cancer Res Treat; 2009 Aug; 116(3):571-5. PubMed ID: 18819000
[TBL] [Abstract][Full Text] [Related]
35. CCND1 G870A polymorphism interaction with cigarette smoking increases lung cancer risk: meta-analyses based on 5008 cases and 5214 controls.
Duan YZ; Zhang L; Liu CC; Zhu B; Zhuo WL; Chen ZT
Mol Biol Rep; 2013 Jul; 40(7):4625-35. PubMed ID: 23653001
[TBL] [Abstract][Full Text] [Related]
36. Cyclin D1 G870A polymorphism is a risk factor for esophageal cancer among Asians.
Zhuo W; Zhang L; Wang Y; Zhu B; Chen Z
Cancer Invest; 2012 Nov; 30(9):630-6. PubMed ID: 23020291
[TBL] [Abstract][Full Text] [Related]
37. CCND1 G870A polymorphism and cervical cancer risk: a case-control study and meta-analysis.
Ni J; Wang M; Wang M; Fu S; Zhou D; Zhang Z; Han S
J Cancer Res Clin Oncol; 2011 Mar; 137(3):489-94. PubMed ID: 20473525
[TBL] [Abstract][Full Text] [Related]
38. Influence of CCND1 G870A polymorphism on the risk of HBV-related HCC and cyclin D1 splicing variant expression in Chinese population.
Zeng Z; Tu J; Cheng J; Yao M; Wu Y; Huang X; Xie X; Zhang X; Lu F; Chen X
Tumour Biol; 2015 Sep; 36(9):6891-900. PubMed ID: 25851350
[TBL] [Abstract][Full Text] [Related]
39. Tumor susceptibility and prognosis of breast cancer associated with the G870A polymorphism of CCND1.
Yu CP; Yu JC; Sun CA; Tzao C; Ho JY; Yen AM
Breast Cancer Res Treat; 2008 Jan; 107(1):95-102. PubMed ID: 18043898
[TBL] [Abstract][Full Text] [Related]
40. Cyclin D1 polymorphism and oral cancer: a meta-analysis.
Wang W; Zhao Y; Yang J; Lin B; Gu H; Cao X; Ge L
Mol Biol Rep; 2013 Jan; 40(1):87-95. PubMed ID: 23111452
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
